 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
Vascular Biogenics
VBLT
I am no longer covering this company.
conference date: November 14, 2022 @ press release only
Vascular Biogenics Trial Nears Full Enrollment, Price Could Jump [September 3, 2021] at Seeking Alpha
Vascular Biogenics: A Buy On Promising Cancer Therapy [April 1, 2020] at Seeking Alpha
Biotech Bargain Basement Buys: VBL Therapeutics [January 23, 2018] at Seeking Alpha
VBL Therapeutics (VBLT) Announces Top-Line Results from Pivotal Phase 3 GLOBE Study in Glioblastoma
| 2022 | |||
| Vascular Biogenics (VBLT) Q4 2021 |
Vascular Biogenics (VBLT) Q1 2022 |
Vascular Biogenics VBLT Q1 2022 press release |
Vascular Biogenics VBLT Q1 2022 press release |
| March 23, 2022 | May 17, 2022 | August 15, 2022 | November 14, 2022 |
| 2021 | |||
| Vascular Biogenics (VBLT) Q4 2020 |
Vascular Biogenics (VBLT) Q1 2021 |
Vascular Biogenics (VBLT) Q2 2021 |
Vascular Biogenics (VBLT) Q3 2021 |
| March 25, 2021 | May 11, 2021 | Aug. 16, 2021 | Nov. 15, 2021 |
| 2020 | |||
| Vascular Biogenics (VBLT) Q4 2019 |
Vascular Biogenics (VBLT) Q1 2020 |
Vascular Biogenics (VBLT) Q2 2020 |
Vascular Biogenics (VBLT) Q3 2020 |
| March 19, 2020 | May 14, 2020 | Aug. 13, 2020 | Nov. 16, 2020 |
| 2019 | |||
| Vascular Biogenics (VBLT) Q4 2018 |
Vascular Biogenics (VBLT) Q1 2019 |
Vascular Biogenics (VBLT) Q2 2019 |
Vascular Biogenics (VBLT) Q3 2019 |
| Mar. 28, 2019 | May 15, 2019 | Aug. 13, 2019 | Nov. 14, 2019 |
2018 |
|||
| Vascular Biogenics (VBLT) |
Vascular Biogenics (VBLT) |
||
March 15, 2018 |
May 17, 2018 |
August 16, 2018 |
Nov. 20, 2018 |
Vascular Biogenics (VBLT) is a clinical-stage biotechnology company specializing in cancer therapies. It is also known as VBL Therapeutics.
Vascular Biogenics (VBLT) web site
I sold mine on 11/16/2022, for a signicant loss
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALNY |
| ALXN |
| AMAT |
| AMGN |
| APRE |
| ARWR |
| BIIB |
| BMY |
| CLDX |
| EPZM |
| GILD |
| GLYC |
| ILMN |
| INO |
| IONS |
| ISRG |
| MCHP |
| PLX |
| REGN |
| RNA |
| SAGE |
| SGEN |
| SYRS |
| VRTX |
| VSTM |
| WBA |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2022 William P. Meyers